Xaliproden chemical structure | |
1-(2-naphthalen-2-ylethyl)-4-[3-(trifluoromethyl)phenyl]-3,6-dihydro-2H-pyridine IUPAC name | |
CAS number 135354-02-8 |
ATC code N07XX03 |
PubChem 128919 |
DrugBank [1] |
Chemical formula | {{{chemical_formula}}} |
Molecular weight | 381.433 g/mol |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Pregnancy category | |
Legal status | |
Routes of administration |
Xaliproden is a drug which has been proposed for use in the treatment of Alzheimer's disease.[1]
References[]
- ↑ Lemaire L, Fournier J, Ponthus C, Le Fur Y, Confort-Gouny S, Vion-Dury J, Keane P, Cozzone P (2002). Magnetic resonance imaging of the neuroprotective effect of xaliproden in rats.. Invest Radiol 37 (6): 321-7. PMID 12021588.